Dolasetron, available commercially as Anzement, is an anti-emetic drug that is especially useful to chemotherapy patients. Its mode of action is as a serotonin 5-HT3 receptor antagonist. A new, more scalable synthetic route to dolasteron was featured in a recent Patent Watch report.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.